TGFB1 and ovarian carcinoma: Guided by this computational information, experiments are underway to verify these co-regulator modules in normal and aberrant conditions such as ovarian cancer, a disease in which dysregulation of TGF-β/SMAD signaling has recently been demonstrated [66].